VOLITIONRX LTD — Director's Dealing 2018

Dec 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2018-12-20

Reporting Person: Skaff Habib (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-20	Option (Right to Buy)	$2.5	D	12500	Disposed	2019-02-18	Common Stock (12500)	Direct
2018-12-20	Option (Right to Buy)	$3	D	12500	Disposed	2020-02-18	Common Stock (12500)	Direct
2018-12-20	Option (Right to Buy)	$2.5	A	12500	Acquired	2020-08-18	Common Stock (12500)	Direct
2018-12-20	Option (Right to Buy)	$3	A	12500	Acquired	2020-08-18	Common Stock (12500)	Direct
2018-12-20	Option (Right to Buy)	$4	D	10000	Disposed	2020-01-23	Common Stock (10000)	Direct
2018-12-20	Option (Right to Buy)	$4	A	10000	Acquired	2021-07-23	Common Stock (10000)	Direct

Footnotes

F1: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on August 18, 2014 and vested in two equal installments at 6 months and at 18 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and both installments expire on August 18, 2020.

F2: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015 and vested in full at 6 months from the date of grant, and were exercisable for four years from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2021.